Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Asthma and COVID-19: a systematic review

Texto completo
Autor(es):
Mendes, Natalia F. [1, 2] ; Jara, Carlos P. [1, 2] ; Mansour, Eli [3] ; Araujo, Eliana P. [1, 2] ; Velloso, Licio A. [2, 3]
Número total de Autores: 5
Afiliação do(s) autor(es):
[1] Univ Estadual Campinas, Sch Nursing, Campinas - Brazil
[2] Univ Estadual Campinas, Obes & Comorbid Res Ctr, Lab Cell Signaling, Inst Biol, Rua Carl Lineaus S-N, BR-13083864 Campinas, SP - Brazil
[3] Univ Estadual Campinas, Dept Internal Med, Clin Immunol & Allergy, Campinas - Brazil
Número total de Afiliações: 3
Tipo de documento: Artigo de Revisão
Fonte: ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY; v. 17, n. 1 JAN 6 2021.
Citações Web of Science: 0
Resumo

BackgroundSevere coronavirus disease-19 (COVID-19) presents with progressive dyspnea, which results from acute lung inflammatory edema leading to hypoxia. As with other infectious diseases that affect the respiratory tract, asthma has been cited as a potential risk factor for severe COVID-19. However, conflicting results have been published over the last few months and the putative association between these two diseases is still unproven.MethodsHere, we systematically reviewed all reports on COVID-19 published since its emergence in December 2019 to June 30, 2020, looking into the description of asthma as a premorbid condition, which could indicate its potential involvement in disease progression.ResultsWe found 372 articles describing the underlying diseases of 161,271 patients diagnosed with COVID-19. Asthma was reported as a premorbid condition in only 2623 patients accounting for 1.6% of all patients.ConclusionsAs the global prevalence of asthma is 4.4%, we conclude that either asthma is not a premorbid condition that contributes to the development of COVID-19 or clinicians and researchers are not accurately describing the premorbidities in COVID-19 patients. (AU)

Processo FAPESP: 13/07607-8 - CMPO - Centro Multidisciplinar de Pesquisa em Obesidade e Doenças Associadas
Beneficiário:Licio Augusto Velloso
Linha de fomento: Auxílio à Pesquisa - Centros de Pesquisa, Inovação e Difusão - CEPIDs
Processo FAPESP: 16/17810-3 - Avaliação da função do TGF-b1 no hipotálamo de animais com diabetes e obesidade induzidos por dieta hiperlipídica
Beneficiário:Natália Ferreira Mendes
Linha de fomento: Bolsas no Brasil - Doutorado